Glaucoma is the name given to a group of eye conditions in which the optic nerve is damaged where it leaves the eye. Although any vision which has been lost to glaucoma cannot be recovered, with early diagnosis, careful monitoring and regular use of the treatments, further damage to vision can be prevented and most patients retain useful sight for life. While there are usually no warning signs, regular eye tests will help detect the onset of the disease. Glaucoma is one of the world's leading causes of blindness. In the UK, about two per cent of the population over 40 have the condition.
The main aim of this project is to develop a safe and effective treatment to prevent conjunctival fibrosis (scaring) in glaucoma.
Despite glaucoma being the second leading cause of blindness globally, the causes of the commonest form remain unclear.
The research proposed bridges glaucoma with genetics and aims towards the development of new, personalised therapeutic platforms for the treatment of glaucoma and ocular hypertension.